| 1 |
Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes | [Lipoatrofia po zastosowaniu długo działaja̧cego analogu insuliny glarginy u 32-letniej pacjentki z cukrzyca̧ typu 1] |
|
| | Dziura, M., Wa̧sikowa, R. | | | Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego. 2008; 14(1): 61-63 | | | [Pubmed] [Google Scholar] | | | 2 |
Insulin glargine in the management of diabetes mellitus: An evidence-based assessment of its clinical efficacy and economic value |
|
| | Clissold, R., Clissold, S. | | | Core Evidence. 2007; 2(2): 89-110 | | | [Pubmed] [Google Scholar] | | | 3 |
No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine |
|
| | Niederkohr RD, Quon A | | | CLINICAL NUCLEAR MEDICINE. 2007; 32 (4): 302-303 | | | [Pubmed] [Google Scholar] | |
|
